Synthetic technique for tamibarotene

A technology of tamibarotene and compounds, which is applied in the field of new synthetic technology of tamibarotene, can solve the problems of cumbersome operation, difficult separation, unsuitable for industrial production, etc., and achieve the effect of simplifying the synthetic route

Inactive Publication Date: 2010-05-19
CHINA PHARM UNIV
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] 1) The synthetic route is long;
[0010] 2) The use of toxic reagent benzene will cause great harm to labor protection and the environment;
[0011] 3) Use mixed acid (nitric acid / sulfuric acid) for nitration, and then use Pd / C for reductive hydrogenation, resulting in serious environmental pollution, dangerous operation, high cost and low yield
[0016] 1) When the Fu Ke reaction product (2-acetylamino-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalene) is recrystallized with ethanol / water mixed solvent, an oily substance will appear, Mixed with the product crystals, it is difficult to separate and affect the yield;
[0017] 2) Nitrogen protection is required in the acyl exchange reaction, and the reaction temperature requires low temperature (-25°C)-room temperature-low temperature (-20°C~-30°C) conversion, and the operation is cumbersome;
[0018] 3) When compound (III) is hydrolyzed into compound (I) in the patent literature, excessive sodium hydroxide is used, and the reaction temperature is too high, so that not only the ester bond is hydrolyzed, but the amide bond is also hydrolyzed, resulting in by-products, low yield, and even Compound (I) could not be obtained
[0019] Therefore above-mentioned two synthetic routes are all unsuitable for industrialized production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthetic technique for tamibarotene
  • Synthetic technique for tamibarotene
  • Synthetic technique for tamibarotene

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0044] The preparation of example one 2,5-dichloro-2,5-dimethylhexane

[0045] Add 24 grams of 2,5-dimethyl-2,5-hexanediol into 400ml of concentrated hydrochloric acid, stir at room temperature for 2 hours, filter out the solid with suction, dissolve it in 50ml of dichloromethane, wash with water until neutral, and anhydrous Dry over magnesium sulfate, filter, and concentrate under reduced pressure to obtain 24.4 g of a white solid with a yield of 81% and a melting point of 65-66°C.

example 2

[0046] The preparation of example two p-phenylcarbamoylbenzoic acid methyl esters (II)

[0047] Dissolve 24.4g of methyl p-chloroformylbenzoate in 200ml of anhydrous dichloromethane, then add 25ml of triethylamine, then slowly add 30ml of aniline, keep the internal temperature at 0-5°C, and stir at room temperature after the dropwise addition After 2 hours, the solid was filtered out with suction, washed with water until neutral, and dried to obtain a light yellow crude product, which was recrystallized from ethanol to obtain 27.3 g of off-white solid, yield 87%, melting point: 194°C-196°C.

[0048] 1 H-NMR (CDCl 3 )δ: 3.95 (3H, s, CH 3 ); 7.19 (1H, t, aromatic H); 7.38 (2H, t, aromatic H); 7.64 (2H, d, aromatic H); 7.91 (2H, d, aromatic H); 7.97 (1H, s, NH) ; 8.12 (2H, d, aromatic H).

example 3 -

[0049] Preparation of Example Three 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalene)carbamoyl]benzoic acid methyl ester (III)

[0050] Add 27.2 grams of compound (II) into 200 ml of anhydrous dichloromethane, then add 27 grams of anhydrous aluminum trichloride and 35 grams of 2,5-dichloro-2,5-dimethylhexane in sequence, and keep the internal temperature Stir for 2 hours at -5 to -10°C. Then the reactant was slowly poured into 250ml of ice water, the organic layer was separated, the aqueous layer was extracted with dichloromethane (60ml×2), the organic layers were combined, washed with water until neutral, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure to obtain The tan residue was recrystallized from n-hexane to obtain a dark yellow solid, and then recrystallized from a methanol / water mixed solvent to obtain 20 g of a light yellow solid with a yield of 52%. Melting point: 212°C-215°C.

[0051] 1 H-NMR (CDCl 3 )δ: 1.28 (6H,...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a synthesis method for the (I) Linarotene (I), a leukemia treatment drug. The invention mainly proposes a novel synthetic route with the steps as follows: the aniline, and p-chlorocarbonyl benzoic methyl ester are used as the raw materials; the intermediate is the p-chlorocarbonyl benzoic methyl ester and can do the cyclization with the 2,5 - dichloro-2 ,5 - dimethyl hexaneunder the anhydrous condition to get the intermediate 4-[(5,6,7,8-tetrahydrocannabinol-5,5,8,8- tetramethyl-2-naphthalene) carbamoyl] methyl benzoate. After the hydrolysis, the 4-[(5,6,7,8-tetrahydrocannabinol-5,5,8,8- tetramethyl-2-naphthalene) carbamoyl] benzoate (I) can be made, that is, the Linarotene. The synthetic route is simple; the operation is convenient and conducive to the environmental protection; the invention is suitable for the industrial production.

Description

technical field [0001] The invention relates to a new synthesis process of tamibarotene. Background technique [0002] Tamibarotene (I) is a RARα agonist designed specifically for acute promyelocytic leukemia (APL) patients who are resistant to all-trans retinoic acid (ATRA) or intolerance to drug toxicity. It is suitable for the treatment of relapsed or refractory cases of APL. Clinical studies have shown that it has the effect of relieving the symptoms of APL patients with ATRA-induced recurrence. Compared with the previous ATRA combined with chemotherapy, it has less side effects and is a promising drug for the treatment of APL. Tamibarotene was developed by Nippon Shinyaku Co., Ltd. and was first listed in Japan on June 13, 2005. [0003] [0004] Existing foreign literature tamibarotene has two synthetic routes: [0005] (1) J.Med.Chem.1988, 31(11): 2182-2191, published synthesis method: [0006] Using 2,5-dimethyl-2,5-hexanediol as raw material, through chlorina...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07C235/84C07C231/02
Inventor 陈国华王含建
Owner CHINA PHARM UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products